Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Deutsche Boerse AG  >  MPH Health Care AG    93M1   DE000A289V03


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

MPH Health Care AG: 1st half of 2020

09/02/2020 | 05:39am EST

DGAP-News: MPH Health Care AG / Key word(s): Half Year Results/Development of Sales
MPH Health Care AG: 1st half of 2020

02.09.2020 / 11:39
The issuer is solely responsible for the content of this announcement.

MPH Health Care AG: 1st half of 2020 - portfolio companies partly affected by corona restrictions. Net Asset Value (NAV) is at 5.58 Euro

Berlin, 02 September 2020. MPH Health Care AG (ISIN: DE000A0L1H32) today reports on the development of the company and the investment portfolio in the first half of 2020. The company's Net Asset Value (NAV) at the end of the first half of 2020 was 5.58 euros per share (previous year 5.86 euros per share). Due to the current uncertainties in connection with the corona pandemic, the listed investments HAEMATO AG and M1 Kliniken AG each decided at their annual general meetings in July 2020 not to pay dividends in order to strengthen liquidity. The shareholders of MPH AG also decided on 22 July 2020 at the Annual General Meeting not to pay a dividend for the past financial year 2019 in order to maintain sufficient financial reserves for further growth.

MPH's listed and major associated companies developed as follows in the first half of 2020:

HAEMATO AG was able to ensure the regular course of business as far as possible despite the corona restrictions with numerous organisational measures and to guarantee a constant supply of goods to customers. With a turnover of 115.8 million Euros in the first half of 2020 the company exceeded the previous year's value by a good 23 %. EBITDA for the first six months amounts to TEUR 2,066, which is also around 23 % above the comparable figure for the previous year of TEUR 1,675. The equity ratio as of 30 June 2020 increased from 56.2 % (previous year) to 61.3 %.

In the first quarter of 2020, M1 Kliniken AG was able to continue its strong growth course of the 2019 financial year. Three new practices (London, Liverpool and Graz) have already been opened. For the second half of 2020, further practice openings are firmly on the agenda.
In the course of the corona pandemic, however, the practices and clinics had to close from 23 March 2020 and could only be reopened step by step in the course of May. Although the M1 is experiencing an ongoing increase in demand for medical and aesthetic services, the two-month closure resulted in a loss of revenue. IFRS consolidated sales in the first half of 2020 amounted to EUR 29.1 million compared to EUR 32.9 million in the first half of 2019. Earnings before taxes (EBT) for the reporting period fell to TEUR 2,523 (after TEUR 5,183 as of 30 June 2019).

For CR Capital Real Estate AG, the fiscal year 2019 developed very positively. In order to set the course for future growth and the expansion of the business model towards a real estate investment company, accounting was changed to IFRS 10 at the end of last year. Due to the valuation of the investments of CR Capital Real Estate AG at fair value, the net income for the year increased to more than EUR 90 million (previous year: EUR 7.8 million). Equity rose to approx. EUR 200 million (previous year: EUR 35.4 million).
At the end of July 2020, CR Capital Real Estate AG announced its intention to establish a real estate investment company in the legal form of a Real Estate Investment Trust (REIT AG) together with financial investors. Investments will mainly be made in newly built residential properties in Berlin and in the Berlin suburbs. With the future REIT AG, CR Capital Real Estate AG will offer private investors lucrative and tax-advantageous investment opportunities in real estate even for smaller amounts.

The half-year report 2020 of MPH Health Care AG is available for download at: www.mph-ag.de/investor-relations.

About MPH Health Care AG:

MPH AG is an investment company with a strategic focus on the purchase, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potentials outside the healthcare market in sectors with strong growth and earnings. MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de

02.09.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A0L1H32
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1126633

End of News DGAP News Service

1126633  02.09.2020 


© EQS 2020
All news about MPH HEALTH CARE AG
2020ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research GmbH): ..
2020EQS/ORIGINAL-RESEARCH : MPH Health Care AG (von First Berlin Equity Research Gmb..
2020PRESS RELEASE : MPH Health Care AG: Preliminary IFRS third quarter 2020 results ..
2020MPH HEALTH CARE AG : Preliminary IFRS third quarter 2020 results published. Equi..
2020MPH HEALTH CARE AG : 1st half of 2020
More news
Sales 2020 17,5 M 21,1 M 21,1 M
Net income 2020 -22,0 M -26,6 M -26,6 M
Net Debt 2020 - - -
P/E ratio 2020 -4,41x
Yield 2020 8,89%
Capitalization 96,3 M 116 M 116 M
Capi. / Sales 2020 5,50x
Capi. / Sales 2021 2,55x
Nbr of Employees 424
Free-Float 100%
Duration : Period :
MPH Health Care AG Technical Analysis Chart | 93M1 | DE000A289V03 | MarketScreener
Income Statement Evolution
Mean consensus BUY
Number of Analysts 2
Average target price 78,43 €
Last Close Price 22,50 €
Spread / Highest target 264%
Spread / Average Target 249%
Spread / Lowest Target 233%
EPS Revisions
Managers and Directors
Patrick Brenske Chairman-Management Board
Andrea Grosse Chairman-Supervisory Board
Sabine Meck Member-Supervisory Board
Ulrich Wandschneider Deputy Chairman-Supervisory Board
Sector and Competitors